• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Cardinal Health

Cardinal Health recalls some saline syringes due to air embolism risk

August 20, 2021 By Sean Whooley

Cardinal Health

Cardinal Health (NYSE:CAH) has initiated a U.S. recall of its Monoject Flush prefilled saline syringes due to an issue with the reintroduction of air. Dublin, Ohio-based Cardinal Health on Aug. 4 recalled approximately 267 million Monoject Flush devices because they have been found to reintroduce air into the syringe after the air has been expelled, […]

Filed Under: Drug-Device Combinations, Featured, Recalls Tagged With: Cardinal Health

Cardinal Health wins new FDA approval for Lymphoseek

June 10, 2021 By Sean Whooley

Cardinal Health

Cardinal Health (NYSE:CAH) announced today that the FDA approved its Lymphoseek injection for pediatric use. Dublin, Ohio-based Cardinal Health touts Lymphoseek — acquired from Navidea Biopharmaceuticals (NYSE:NAVB) in November 2016 — as the first and only radiopharmaceutical agent specifically designed for targeted lymphatic mapping and guiding sentinel lymph node biopsies (SLNB). The new indication will expand […]

Filed Under: Diagnostics, Drug-Device Combinations, Featured, Oncology, Pediatrics, Pharmaceuticals Tagged With: Cardinal Health, FDA

Report: Global syringes market set to reach $32.4B by 2027

February 12, 2021 By Sean Whooley

Market research released this week suggests that the global syringes market will reach $32.39 billion by 2027. Allied Market Research published a report estimating the global syringes market sat at $15.34 billion in 2019, with expectations of hitting $32.39 billion in value by 2027, with a compound annual growth rate (CAGR) of 9.6% from 2020 […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: bbraun, Becton Dickinson, Cardinal Health, Medline Industries, Retractable Technologies, syringes, Terumo Corp.

Medinol stent performs just as well as Medtronic Resolute, study says

January 6, 2020 By Chris Newmarker

Medinol EluNIR drug-eluting stent

The EluNIR drug-eluting stent made by Medinol performed just as well as the Resolute Integrity or Resolute Onyx stents from Medtronic (NYSE:MDT), according to new clinical study results from an international team of researchers. The randomized clinical trial — conducted by researchers from the U.S., Israel, Canada and the Netherlands — involved 2,221 people and compared […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Stents Tagged With: Cardinal Health, medinol, Medtronic

Sollis lands $50m for extended-release pain-relief drug

April 20, 2018 By Sarah Faulkner

Sollis Therapeutics closed a $50 million round to support a pivotal trial of its non-opioid pain-reliever, according to Ohio-based translator NeuroTechnology Innovations Translator. Deerfield Management led the funding round and was joined by NIT collaborators, including Medtronic (NYSE:MDT), Cardinal Health and Ohio State University. NIT founded Sollis Therapeutics last year to help facilitate the development and commercialization […]

Filed Under: Featured, Funding Roundup, Pain Management Tagged With: Cardinal Health, Medtronic, sollistherapeutics

Cardinal Health donates 80,000 Narcan doses to first responders in Appalachia

April 5, 2018 By Sarah Faulkner

Cardinal Health

Cardinal Health today began its donation of more than 80,000 doses of Narcan, a nasal spray designed to reverse opioid overdoses, to community organizations in Ohio, Kentucky, Tennessee and West Virginia. The donation is part of the company’s Opioid Action Program – a pilot program launched last year to bring solutions to first responders, communities […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Cardinal Health

Cordis, Medinol tout first commercial implants of Elunir drug-eluting stent in U.S.

January 11, 2018 By Sarah Faulkner

Cordis, Medinol

Cordis and Medinol announced today that the first commercial uses of the Elunir drug-eluting stent in the U.S. were performed at New York-Presbyterian Hospital/Columbia University Medical Center and the Piedmont Heart Institute in Atlanta. The Elunir stent, developed by Medinol and distributed by Cordis, features a metallic spring tip and the narrowest strut width of […]

Filed Under: Drug-Device Combinations, Featured, Implants, Pharmaceuticals, Vascular, Wall Street Beat Tagged With: Cardinal Health, cordis, medinol

Medtech stories we missed: Feb. 3, 2017

February 3, 2017 By Chris Newmarker

flashlight MassDevice stories missed

From disappointing Getinge earnings to a $2.25 billion U.S. Defense Department contract for Cardinal Health to a host of 510(k) clearances, here are seven recent medtech stories that are still worth a mention. 1. Getinge disappoints on earnings—again Getinge stock took a nearly 10% tumble last week after releasing earnings that Reuters says lagged analyst […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), mHealth (Mobile Health) Tagged With: Biogen, Biolase, Bioverativ, Cambridge Cognition Holdings, Cardinal Health, Getinge, medtech, Precision Spine, U.S. Department of Defese, Zimmer Biomet

Navidea deals NA Lymphoseek rights to Cardinal Health in $310m deal

November 28, 2016 By Sarah Faulkner

Navidea Biopharmaceuticals (NYSE:NAVB) said today that it inked a definitive asset purchase agreement with Cardinal Health (NYSE:CAH) for its Lymphoseek product. Dublin, Ohio-based Navidea said it’s due to receive $80 million at closing for the lymphatic mapping and lymph node biopsy product, plus the opportunity for $230 million in milestone payments through 2026. More than $20 […]

Filed Under: Diagnostics, Featured, Mergers & Acquisitions, Oncology, Wall Street Beat Tagged With: Cardinal Health, Navidea Biopharmaceuticals

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS